Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.71 |
| ▸ | RECQL | P46063 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | HRH1 | P35367 | 1/20 | 0.65 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | THPO | P40225 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31011113 | 1.00 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL30513874 | 1.00 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| Carnitine SCHEMBL994915 | 0.95 | MEN1 (0.65) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL994842 | 0.89 | MEN1 (0.57) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL464880 | 0.88 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL16238330 | 0.88 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL232682 | 0.88 | MEN1 (0.73) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| Hydrochloric Acid SCHEMBL9465317 | 0.87 | MEN1 (0.71) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL4962977 | 0.86 | MEN1 (0.75) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL4962982 | 0.86 | MEN1 (0.75) | MEN1KMT2ACYP2C19RECQLCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720665-A1 | METHOD OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | Molecular You Corporation (CA) | 2026-04-08 | — | — | EP | claimed |
| CN-120195296-A | Combined metabolic marker for judging insulin resistance risk of high-fat diet mice exposed to bisphenol S in perinatal period of female mice and detection kit thereof | 集美大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119322179-A | Application of biomarker in predicting diabetes strengthening treatment effect and kit | 中日友好医院(中日友好临床医学研究所) | 2025-01-17 | — | — | CN | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| WO-2024239122-A1 | METHOD OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | Molecular You Corporation (CA) | 2024-11-28 | — | — | WO | claimed |
| CN-118067976-A | Application of metabolic markers in preparation of products for predicting or prognosis evaluation of diabetes curative effect | 首都医科大学附属北京友谊医院 | 2024-05-24 | — | — | CN | claimed |
| CN-118033023-A | Lung cancer biomarker and application thereof | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2024-05-14 | — | — | CN | claimed |
| CN-117074589-A | Method for detecting succinylacetone, amino acid and carnitine in maternal amniotic fluid | 山东英盛生物技术有限公司 | 2023-11-17 | — | — | CN | claimed |
| US-20230324349-A1 | ACYLCARNITINE ANALYSIS METHOD AND ACYLCARNITINE ANALYSIS DEVICE | SHIMADZU CORPORATION (JP) | 2023-10-12 | — | — | US | claimed |
| CN-116804677-A | Biomarker for early detection of aspiration pneumonia and application thereof | 福建医科大学附属第二医院 | 2023-09-26 | — | — | CN | claimed |
| WO-2013060788-A2 | METHOD AND USE OF METABOLITES FOR THE DIAGNOSIS AND DIFFERENTIATION OF NEONATAL ENCEPHALOPATHY | INFANDX AG (DE) | 2013-05-02 | — | — | WO | claimed |
| EP-2587264-A1 | Method and use of metabolites for the diagnosis and differentiation of neonatal encephalopathy | InfanDx AG (DE) | 2013-05-01 | — | — | EP | claimed |
| US-20120208282-A1 | Method For Normalization in Metabolomics Analysis Methods with Endogenous Reference Metabolites. | BIOCRATES LIFE SCIENCES AG | 2012-08-16 | — | — | US | claimed |
| US-20120136581-A1 | Method of Diagnosing Asphyxia | BIOCRATES LIFE SCIENCES AG (AT) | 2012-05-31 | — | — | US | claimed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | claimed |
| EP-2427773-A1 | METHOD OF DIAGNOSING ASPHYXIA | Keller, Matthias (DE) | 2012-03-14 | — | — | EP | claimed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | claimed |
| EP-2270699-A1 | Method for normalization in metabolomics analysis methods with endogenous reference metabolites | BIOCRATES Life Sciences AG (AT) | 2011-01-05 | — | — | EP | claimed |
| WO-2010128054-A1 | METHOD OF DIAGNOSING ASPHYXIA | BIOCRATES LIFE SCIENCES AG (AT) | 2010-11-11 | — | — | WO | claimed |
| EP-2249161-A1 | Method of diagnosing asphyxia | BIOCRATES Life Sciences AG (AT) | 2010-11-10 | — | — | EP | claimed |